Ji Pang
Zhenjiang, 212013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
PKG II secreted via the classical endoplasmic reticulum-Golgi apparatus secretory pathway blocks the activation of EGFR through phosporalting its threonine 406 and has an anti-tumor effect.
Journal: Frontiers in bioscience (Landmark edition)
Published: December 18, 2021
Secretory type II cGMP-dependent protein kinase blocks activation of PDGFRβ via Ser254 in gastric cancer cells.
Journal: Cell biology international
Published: September 14, 2021
Type II cGMP-dependent protein kinase phosphorylates EGFR at threonine 669 and thereby inhibits its activation.
Journal: Biochemical and biophysical research communications
Published: July 24, 2019
Active PKG II inhibited the growth and migration of ovarian cancer cells through blocking Raf/MEK and PI3K/Akt signaling pathways.
Journal: Bioscience reports
Published: February 15, 2019
PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells.
Journal: Cell biology international
Published: February 22, 2018
Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: February 06, 2018
Cross-linked hyaluronan gel inhibits the growth and metastasis of ovarian carcinoma.
Journal: Journal of ovarian research
Published: October 19, 2017
PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines.
Journal: Cell biology international
Published: August 17, 2017
The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR-associated signalling cascades.
Journal: Therapeutic advances in medical oncology
Published: August 17, 2017
[Corrigendum] Type II cGMP‑dependent protein kinase inhibits the migration, invasion and proliferation of several types of human cancer cells.
Journal: Molecular medicine reports
Published: November 15, 2016
Type II cGMP‑dependent protein kinase inhibits the migration, invasion and proliferation of several types of human cancer cells.
Journal: Molecular medicine reports
Published: November 15, 2016
Last Updated: 09/26/2026